# BIOMARKERS FOR DRUG SELECTION IN DEPRESSION

> **NCT07269886** · — · COMPLETED · sponsor: **Neomente SAS** · enrollment: 79 (actual)

## Conditions studied

- Depression - Major Depressive Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07269886
- **Lead sponsor:** Neomente SAS
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-18
- **Primary completion:** 2022-10-16
- **Final completion:** 2025-06-30
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07269886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07269886, "BIOMARKERS FOR DRUG SELECTION IN DEPRESSION". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT07269886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*